Cargando…

A Population-Based Study: How to Identify High-Risk T1–2 Esophageal Cancer Patients?

BACKGROUND: Due to individualized conditions of lymph node metastasis (LNM) and distant metastasis (DM), the following therapeutic strategy and diagnosis of T1–2 esophageal cancer (ESCA) patients are varied. A prediction model for identifying risk factors for LNM, DM, and overall survival (OS) of hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yiming, Wu, Shuangshuang, Tao, Linghui, Xu, Guoshu, Chen, Jiabin, Feng, Zhengquan, Lu, Chao, Wan, Yanli, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710781/ https://www.ncbi.nlm.nih.gov/pubmed/34966675 http://dx.doi.org/10.3389/fonc.2021.766181

Ejemplares similares

Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis
por: Qi, Yiming, et al.
Publicado: (2021)

How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome
por: Li, Na, et al.
Publicado: (2021)

Development and validation of the thyroid cancer self-perceived discrimination scale to identify patients at high risk for psychological problems
por: Liu, Zhi-jin, et al.
Publicado: (2023)

A Nomogram for Predicting the Risk of Radiotherapy-Related Esophageal Fistula in Esophageal Cancer Patients
por: Gui, Zhongxuan, et al.
Publicado: (2022)

Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study
por: Guo, Jida, et al.
Publicado: (2021)

Estimating Individualized Absolute Risk for Esophageal Squamous Cell Carcinoma: A Population-Based Study in High-Risk Areas of China
por: Shen, Yi, et al.
Publicado: (2021)

Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application
por: Zhu, Yu-Ge, et al.
Publicado: (2021)

A Model to Identify Candidates for Lymph Node Dissection Among Patients With High-Risk Endometrial Endometrioid Carcinoma According to Mayo Criteria
por: Lu, Wen, et al.
Publicado: (2022)

A population-based investigation: How to identify high-risk T1-2N0 esophageal cancer patients?
por: Luo, Peng, et al.
Publicado: (2023)

Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma
por: Chan-Jun, Zhen, et al.
Publicado: (2023)

The Clinical Application of Neoantigens in Esophageal Cancer
por: Gu, Yi-Min, et al.
Publicado: (2021)

Association of Serum Pepsinogens With Esophageal Squamous Cell Carcinoma Risk: A Systematic Review and Meta-Analysis
por: Yang, Zhen-Xiao, et al.
Publicado: (2022)

Clinicopathological characteristics of synchronous multiple primary early esophageal cancer and risk factors for multiple lesions
por: Su, Jing, et al.
Publicado: (2023)

Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma
por: Sun, Lu, et al.
Publicado: (2023)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy
por: Gao, Yiming, et al.
Publicado: (2022)

Hepatic Metastasis in Newly Diagnosed Esophageal Cancer: A Population-Based Study
por: Li, Huawei, et al.
Publicado: (2021)

Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough?
por: Herrera, Luis J.
Publicado: (2009)

Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma
por: Huang, Yuting, et al.
Publicado: (2022)

Cancer of Pharyngoesophageal Junction: A Different Subtype From Hypopharyngeal and Cervical Esophageal Cancer?
por: Li, Xiaoyu, et al.
Publicado: (2021)

CT-based radiomics for predicting radio-chemotherapy response and overall survival in nonsurgical esophageal carcinoma
por: Li, Chao, et al.
Publicado: (2023)

Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2014)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Risk factors for metachronous esophageal squamous cell carcinoma after endoscopic or surgical resection of esophageal carcinoma: a systematic review and meta-analysis
por: Du, Jie, et al.
Publicado: (2023)

Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
por: Lu, Chenglin, et al.
Publicado: (2022)

Development and validation of a novel prognostic model for patients with surgically resected esophageal squamous cell carcinoma
por: Hu, Haiyang, et al.
Publicado: (2022)

Risk Factors and Genetic Biomarkers of Multiple Primary Cancers in Esophageal Cancer Patients
por: Yang, Pei-Wen, et al.
Publicado: (2021)

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2023)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer
por: Li, Hanming, et al.
Publicado: (2021)

Clinical characteristics and risk factors for 30-day mortality in esophageal cancer patients with upper gastrointestinal bleeding: a multicenter study
por: Lu, Sz-Wei, et al.
Publicado: (2023)

Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer
por: Wu, Rong, et al.
Publicado: (2020)

OSeac: An Online Survival Analysis Tool for Esophageal Adenocarcinoma
por: Wang, Qiang, et al.
Publicado: (2020)

Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis
por: Gu, Yi-Min, et al.
Publicado: (2021)

Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis
por: Ma, Shengling, et al.
Publicado: (2020)

Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2021)

Prognostic Role of ABO Blood Type in Operable Esophageal Cancer: Analysis of 2179 Southern Chinese Patients
por: Zhang, Shuishen, et al.
Publicado: (2020)

Prognostic Value of Pre-Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2020)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

A Case–Control Study of ADCY9 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in the Chinese Han Population
por: Chao, Xu, et al.
Publicado: (2020)

LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting With MLL2/H3K4me3 to Upregulate FOXP4
por: Niu, Yunfeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r1ajn19hc2lvu6i47c750uitih